Biblio

Author Title [ Type(Desc)] Year
Filters: Author is Guo, Qianqian  [Clear All Filters]
Journal Article
Qin H, Zhou Y, Liu H, Yuan Y, Guo Q, Yuan M, Xi T, Zhang YJ. 1-Benzylimidazole attenuates the stemness of breast cancer cells through partially targeting CYP4Z1. Environ Toxicol. 2023.
Zhang G, Wang D, Ren J, Li J, Guo Q, Shi L, Li C. Antler stem cell-derived exosomes promote regenerative wound healing via fibroblast-to-myofibroblast transition inhibition. J Biol Eng. 2023;17(1):67.
Wang D, Ren J, Li J, Li X, Ying J, Jiang T, Wang Z, Pan Z, Guo Q, Li C, et al. Conditioned Media from Deer Antler Stem Cells Effectively Alleviate Type 1 Diabetes Mellitus Possibly via Inhibiting the NF-κB Signaling Pathway. Front Biosci (Landmark Ed). 2024;29(3):96.
Che Y, Chen G, Guo Q, Duan Y, Feng H, Xia Q. Gut microbial metabolite butyrate improves anticancer therapy by regulating intracellular calcium homeostasis. Hepatology. 2023.
Dasgupta D, Nakao Y, Mauer AS, Thompson JM, Sehrawat TS, Liao C-Y, Krishnan A, Lucien F, Guo Q, Liu M, et al. IRE1A Stimulates Hepatocyte-derived Extracellular Vesicles That Promote Inflammation in Mice With Steatohepatitis. Gastroenterology. 2020.
Chen H, Hou S, Zhang H, Zhou B, Xi H, Li X, Lufeng Z, Guo Q. MiR-375 impairs breast cancer cell stemness by targeting the KLF5/G6PD signaling axis. Environ Toxicol. 2024.
Zhao Q, Liu Y, Wang T, Yang Y, Ni H, Liu H, Guo Q, Xi T, Zheng L. MiR-375 inhibits the stemness of breast cancer cells by blocking the JAK2/STAT3 signaling. Eur J Pharmacol. 2020:173359.
Yang Y, Lu Y, Zhang C, Guo Q, Zhang W, Wang T, Xia Z, Liu J, Cheng X, Xi T, et al. Phenazine derivatives attenuate the stemness of breast cancer cells through triggering ferroptosis. Cell Mol Life Sci. 2022;79(7):360.
Guo Q, Liu Z, Zheng J, Zhao H, Li C. Substances for regenerative wound healing during antler renewal stimulated scar-less restoration of rat cutaneous wounds. Cell Tissue Res. 2021.